We received a new FDA communication dated August 3, 2022 about benzodiazepine use during pregnancy: This communication is to inform you that FDA is requiring manufacturers of all benzodiazepine medicines to update and standardize the…
Our director is presenting her lived benzodiazepine experience as a keynote speaker for the California Society of Addiction Medicine’s 2022 conference, August 24 through the 27th. The California Society of Addiction Medicine is the largest…
A documentary project about the pharmaceutical industry’s history is seeking individuals willing to have research conversations about their personal experiences with Valium (diazepam). There is the possibility of an on-camera interview as well. Requirements: You…
The benzodiazepine experience survey was designed by Dr. Jane Macoubrie, a professor of communications and member of BIC’s general advisory board, and Dr. Christy Huff, director of Benzodiazepine Information Coalition, who both have lived experience…
Please join the Colorado Consortium’s Benzodiazepine Action Work Group for our free CME lunch and learn webinar series. Webinar topics include alternative treatments to BZDs, consequences of BZD prescribed use, BZD Induced Neurologic Dysfunction (BIND),…
One day back in August of 2020, I was using the shared laundry room in my condominium building when I saw what appeared to be a water stain on the drywall just above one of…
A new benzodiazepine was approved by the FDA in August, 2021. Loreev XR (extended-release lorazepam) is a once daily benzodiazepine formulation indicated for the treatment of anxiety disorders in adults. Loreev comes in 1 mg 2mg…
The summit features presenters: Prof. Joanna Moncrieff William F. Pettit, Jr, M.D. Adele Framer Jamie Smart James Moore Christy Huff, M.D. Dr. Anne Guy Terry Rubenstein Dr. Elizabeth Corcoran Dr. Amy Johnson Dr. Bryan McElroy…
